Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 31 AL 45

Clinical assessment of Tourette syndrome and tic disorders

Cohen SC, Leckman JF, Bloch MH.

Neurosci Biobehav Rev. 2013 Jul;37(6):997-1007. doi: 10.1016/j.neubiorev.2012.11.013. Epub 2012 Dec 1.

Tic disorders and Tourette's syndrome

Plessen KJ.

Eur Child Adolesc Psychiatry. 2013 Feb;22 Suppl 1:S55-60. doi: 10.1007/s00787-012-0362-x.

The functional anatomy of Gilles de la Tourette syndrome

Ganos C, Roessner V, Münchau A.

Neurosci Biobehav Rev. 2013 Jul;37(6):1050-62. doi: 10.1016/j.neubiorev.2012.11.004. Epub 2012 Dec 10.

Behavioral and motor improvement after deep brain stimulation of the globus pallidus externus in a case of Tourette's syndrome

Piedimonte F, Andreani JC, Piedimonte L, Graff P, Bacaro V, Micheli F, Vilela Filho O.

Neuromodulation. 2013 Jan-Feb;16(1):55-8; discussion 58. doi: 10.1111/j.1525-1403.2012.00526.x. Epub 2012 Dec 14.

The basal ganglia: motor and cognitive relationships in a clinical neurobehavioral context

Leisman G, Melillo R.

Rev Neurosci. 2013;24(1):9-25. doi: 10.1515/revneuro-2012-0067.

Thalamic deep brain stimulation for Tourette syndrome

Ackermans L, Neuner I, Temel Y, Duits A, Kuhn J, Visser-Vandewalle V.

Behav Neurol. 2013;27(1):133-8. doi: 10.3233/BEN-120301.

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

Cortese S, Holtmann M, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Graham J, Taylor E, Sergeant J; European ADHD Guidelines Group.

J Child Psychol Psychiatry. 2013 Mar;54(3):227-46. doi: 10.1111/jcpp.12036. Epub 2013 Jan 7.

Immune-mediated animal models of Tourette syndrome

Hornig M, Lipkin WI.

Neurosci Biobehav Rev. 2013 Jul;37(6):1120-38. doi: 10.1016/j.neubiorev.2013.01.007. Epub 2013 Jan 10.

Glioblastoma tumor initiating cells: therapeutic strategies targeting apoptosis and microRNA pathways

Liu J, Albrecht AM, Ni X, Yang J, Li M.

Curr Mol Med. 2013 Mar;13(3):352-7.

The genetic basis of Gilles de la Tourette Syndrome

Paschou P.

Neurosci Biobehav Rev. 2013 Jul;37(6):1026-39. doi: 10.1016/j.neubiorev.2013.01.016. Epub 2013 Jan 17.

The pharmacology of Tourette syndrome

Thomas R, Cavanna AE.

J Neural Transm (Vienna). 2013 Apr;120(4):689-94. doi: 10.1007/s00702-013-0979-z. Epub 2013 Jan 30.

A critical review of the use of telephone tests to identify cognitive impairment in epidemiology and clinical research

Herr M, Ankri J.

J Telemed Telecare. 2013 Jan;19(1):45-54. doi: 10.1177/1357633X12474962. Epub 2013 Feb 6.

Type IIB thyroplasty for phonic tics in a pediatric patient with autism spectrum disorder: a case report

Ahmed MM, Heckman WW, Dailey SH.

J Voice. 2013 Mar;27(2):242-4. doi: 10.1016/j.jvoice.2012.10.015. Epub 2013 Feb 11.

Symptom dimensions are associated with age of onset and clinical course of obsessive-compulsive disorder

Kichuk SA, Torres AR, Fontenelle LF, Rosário MC, Shavitt RG, Miguel EC, Pittenger C, Bloch MH.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:233-9. doi: 10.1016/j.pnpbp.2013.02.003. Epub 2013 Feb 12.

Paliperidone in the treatment of Tourette's syndrome with comorbid schizophrenia

Guan CH, Tsai SJ.

Psychiatry Clin Neurosci. 2013 Feb;67(2):128. doi: 10.1111/pcn.12013.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias